The Prostate Cancer Foundation Appoints Christine Jones as Chief Operating Officer
SANTA MONICA, Calif., August 1, 2018 – The Prostate Cancer Foundation (PCF) today announced that Christine Jones has been appointed Chief Operating Officer effective immediately reporting to Jonathan W. Simons,...Read More
Genomic Landscape of Metastatic Prostate Cancer Unveiled in New Study
A comprehensive genetic analysis of metastatic prostate cancer has, for the first time, revealed a number of major ways in which abnormal alterations of the genome propel this aggressive form...Read More
NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men
The largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men has begun. The $26.5 million study is called RESPOND, or Research...Read More
FDA Approves Enzalutamide (Xtandi) for Non-Metastatic Castration-Resistant Prostate Cancer
July 13, 2018 – Today the U.S. Food and Drug Administration (FDA) approved enzalutamide (Xtandi) for the treatment of non-metastatic castration-resistant prostate cancer (non-metastatic CRPC). Non-metastatic CRPC is a clinical...Read More
Deadly Form of Advanced Prostate Cancer is Common, Calls for Distinct Treatment
Original article issued by UCSF News. A new study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that a surprisingly large...Read More
Tumors Grown in the Lab Provide Insights on Rare Prostate Cancer
Original article issued by Weill Cornell Medicine. Growing miniature tumors from patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer,...Read More
How Your Spit May Help Doctors Diagnose Prostate Cancer
Original article issued by Healthline. It might seem inconceivable that a simple saliva test can tell you your chances of developing cancer. But evidently it can. And the reason is crude...Read More
Researchers find prostate cancer drug byproduct can fuel cancer cells
Original press release issued by: Cleveland Clinic. A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to...Read More
New Study Identifies Another Opportunity for Precision Immunotherapy in Prostate Cancer
A new Prostate Cancer Foundation (PCF)-funded study published today in the scientific journal Cell has identified a new subtype of advanced prostate cancer – one which may be treatable with...Read More
Non-coding DNA reveals a route by which advanced prostate cancer resists treatment
More than three quarters of metastatic prostate cancers that resist hormone-blocking therapies may harbor several duplicates of both the gene for a treatment resistance factor called the androgen receptor (AR)...Read More